small, medium, and large-sized eligible entities; and

sites located in different geographic areas, including rural and urban areas.

a medical school;

a children’s hospital;

a cancer center;

a community-based medical facility; or

any other entity with significant experience and expertise in carrying out the activities described in paragraph (1).

design of models of follow-up care, monitoring, and other survivorship programs (including peer support and mentoring programs);

development of models for providing multidisciplinary care;

dissemination of information to health care providers about culturally and linguistically appropriate follow-up care for cancer survivors and their families, as appropriate and practicable;

development of psychosocial and support programs to improve the quality of life of cancer survivors and their families, which may include peer support and mentoring programs;

design tools to support the secure electronic transfer of treatment information and care summaries between health care providers or, as applicable and appropriate, longitudinal childhood cancer survivorship cohorts (including risk factors and a plan for recommended follow-up care);

dissemination of the information and programs described in clauses (i) through (v) to other health care providers (including primary care physicians and internists) and to cancer survivors and their families, where appropriate and in accordance with Federal and State law; and

development of initiatives that promote the coordination and effective transition of care between cancer care providers, primary care physicians, mental health professionals, and other health care professionals, as appropriate, including models that use a team-based or multi-disciplinary approach to care.